$46.38
-0.97-2.05%
In chiusura: -
$46.38
N/A
After hour: 4:00 PM EDT
Comments
Loading...
Guidance e previsioni
Collegium Pharmaceutical fornisce indicazioni su EPS e ricavi futuri, offrendo agli investitori informazioni su quanto la società prevede di guadagnare nei prossimi periodi.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
11/06/2025 | COLL | Collegium Pharmaceutical | FY | 2025 | — | — | — | $775.00M | $785.00M | $752.29M | |
08/07/2025 | COLL | Collegium Pharmaceutical | FY | 2025 | — | — | — | $745.00M | $760.00M | $746.49M | |
05/08/2025 | COLL | Collegium Pharmaceutical | FY | 2025 | — | — | — | $735.00M | $750.00M | $742.47M | |
02/27/2025 | COLL | Collegium Pharmaceutical | FY | 2025 | — | — | — | $735.00M | $750.00M | $740.44M | |
01/08/2025 | COLL | Collegium Pharmaceutical | FY | 2025 | — | — | — | $735.00M | $750.00M | $739.84M | |
11/07/2024 | COLL | Collegium Pharmaceutical | FY | 2024 | — | — | — | $620.00M | $635.00M | $625.37M | |
08/08/2024 | COLL | Collegium Pharmaceutical | FY | 2024 | — | — | — | $580.00M | $595.00M | $605.76M | |
05/09/2024 | COLL | Collegium Pharmaceutical | FY | 2024 | — | — | — | $580.00M | $595.00M | $582.25M | |
02/22/2024 | COLL | Collegium Pharmaceutical | FY | 2024 | — | — | — | $580.00M | $595.00M | $583.46M | |
01/03/2024 | COLL | Collegium Pharmaceutical | FY | 2024 | — | — | — | $580.00M | $595.00M | $581.19M | |
11/07/2023 | COLL | Collegium Pharmaceutical | FY | 2023 | — | — | — | $565.00M | $570.00M | $563.40M | |
08/03/2023 | COLL | Collegium Pharmaceutical | FY | 2023 | — | — | — | $565.00M | $580.00M | $570.46M | |
05/04/2023 | COLL | Collegium Pharmaceutical | FY | 2023 | — | — | — | $565.00M | $580.00M | $569.68M | |
02/23/2023 | COLL | Collegium Pharmaceutical | FY | 2023 | — | — | — | $565.00M | $580.00M | $569.72M | |
02/06/2023 | COLL | Collegium Pharmaceutical | Q4 | 2022 | — | — | — | $125.70M | $128.20M | $123.17M | |
02/06/2023 | COLL | Collegium Pharmaceutical | FY | 2022 | — | — | — | $460.00M | $462.50M | $457.44M | |
01/04/2023 | COLL | Collegium Pharmaceutical | FY | 2023 | — | — | — | $565.00M | $580.00M | $550.58M | |
11/03/2022 | COLL | Collegium Pharmaceutical | FY | 2022 | — | — | — | $455.00M | $465.00M | $455.59M | |
08/04/2022 | COLL | Collegium Pharmaceutical | FY | 2022 | — | — | — | $450.00M | $465.00M | $455.26M | |
05/10/2022 | COLL | Collegium Pharmaceutical | FY | 2022 | — | — | — | $450.00M | $465.00M | $448.72M | |
04/05/2022 | COLL | Collegium Pharmaceutical | FY | 2022 | — | — | — | $450.00M | $465.00M | $436.19M | |
02/24/2022 | COLL | Collegium Pharmaceutical | FY | 2022 | — | — | — | $315.00M | $330.00M | $411.53M |
FAQ
Qual è la guidance più recente per Collegium Pharmaceutical (COLL)?
Negli ultimi mesi non sono state riportate guidance specifiche sulle vendite o sugli utili di Collegium Pharmaceutical.
Sfoglia guidance e previsioni su tutte le azioni.